Online registration is now closed. Online certificate retrieval will be available shortly.
Neuropsychiatric disorders are among the most common illnesses treated by physicians. The past year has produced tremendous increases in our understanding of these conditions. Mounting evidence indicates that a wide range of illnesses, including depression and anxiety disorders, can best be treated with medications and psychotherapy. For some patients, such as those with more severe illness, medication may be the mainstay of treatment; for other patients, such as women who are pregnant or breastfeeding, the choice of treatment can be more difficult. How can we choose among the available treatments to achieve the best outcomes?
Even with the most advanced treatment methods, some illnesses remain resistant to treatment. New approaches are needed to ensure the best long-term outcomes for dysthymic disorder, “double depression,” and other chronic conditions. Some illnesses, such as Body Dysmorphic Disorder, may remain resistant to acute treatment and require different long-term strategies. Recent studies also have helped to identify those who are at greatest risk for self-destructive behavior, including suicide. What approaches are most effective for treating patients with these illnesses and behaviors?
The boundary between illnesses that are the province of psychiatry, neurology, or another specialty also is fading. A special focus of this year's conference is an advanced imaging and treatment techniques at the frontier of psychiatric and neurologic practice. Advanced brain imaging techniques are enhancing our understanding of the origins of neuropsychiatric disorders, and how treatments work. We also are able to use neuroimaging to study those at risk for neurodegenerative diseases and identify these illnesses at their earliest stages, guiding us towards the development of new and more effective treatments.
This conference will update practitioners in psychiatry, neurology, and primary care on the state of the art in understanding and treating neuropsychiatric disorders. In a series of half-day workshops, an expert faculty will review advances in clinical neuroscience that have yielded insights into causes of neuropsychiatric disorders. Participants will learn the latest developments in psychotherapy that can benefit patients across the life span. Sessions will provide a framework for understanding neuropsychiatric illnesses, and a practical guide to the most sophisticated treatments available for each disorder. All participants will receive a complete syllabus, including lecture outlines and key slides.
Andrew F. Leuchter, M.D.
Sheraton Kauai Resort
2440 Hoonani Road
Poipu Beach, Hawaii 96756